Italia markets open in 8 hours 55 minutes

Dow Jones
38.571,03
-115,29(-0,30%)
Nasdaq
16.828,67
+93,65(+0,56%)
Nikkei 225
38.923,03
+435,13(+1,13%)
EUR/USD
1,0911
+0,0057(+0,52%)
Bitcoin EUR
63.273,41
+1.050,73(+1,69%)
CMC Crypto 200
1.450,10
-17,83(-1,21%)

NVCR Jun 2024 17.500 put

OPR - OPR Prezzo differito. Valuta in USD.

Aggiungi a watchlist

0,0500

-0,0500

(-50,00%)

In data: 03:58PM EDT. Mercato aperto.

GlobeNewswire
Zai Lab and Novocure Announce LUNAR Phase 3 Clinical Trial Demonstrates Statistically Significant and Clinically Meaningful Extension in Overall Survival for Patients with Metastatic Non-Small Cell Lung Cancer After Platinum-Based Therapies
Tumor Treating Fields therapy together with standard of care provided a statistically significant and clinically meaningful 3-month improvement in median overall survival versus standard of care with no added systemic toxicities Tumor Treating Fields therapy together with immune checkpoint inhibitors resulted in an unprecedented 8-month improvement in median overall survival LUNAR is the first phase 3 clinical trial in more than seven years to show a significant extension in overall survival in